Publications

• Michael C. Barnes, Special Issue Editor, Legal, Legislative, and Regulatory Approaches to Reducing Opioid Use Disorder and Opioid-Involved Poisonings, 19 J. Opioid Manag. 7 (2023).

• Michael C. Barnes, et al., Demanding Better: A Case for Increased Funding and Involvement of State Medical Boards in Response to America’s Drug Abuse Crisis, 106(3) J. Med. Reg. 6 (2020).

• Michael C. Barnes & Angie Drakulich, Revisiting Documentation, Practical Pain Management (2019).

• Michael C. Barnes, I’m Not a Doctor, But I Play One in D.C.: Federal Action and Its Impact on Pain Care, 7 PAINWeek J. 34 (2019).

• Michael C. Barnes, A More Sensible Surge: Ending DOJ’s Indiscriminate Raids of Healthcare Providers, 8.1 Legis. & Pol’y Brief 7 (2019).

• Michael C. Barnes & Daniel C. McClughen, Warm Handoffs: The Duty of and Legal Issues Surrounding Emergency Departments in Reducing the Risk of Subsequent Drug Overdoses, U. Mem. L. Rev 1100 (2019).
• Michael C. Barnes, et al., Potential Impact of Texas et al v United States on Persons with Substance Use Disorder, ABA Health eSource (October 2018).

• Michael C. Barnes, Diligence and Documentation: Managing the Risks of Prescribing Controlled Substances, 5 PAINWeek J. 52 (2017).

• Michael C. Barnes, et al., What’s in a Number? Recommending Practicality in the DATA 2000 Patient Limits, 12 J. Opioid Manag. 243 (2016).

• Michael C. Barnes, et al., A Call for Differential Diagnosis of Non-Specific Low Back Pain to Reduce Opioid Abuse, 101 J. Med. Reg. 39 (2015).

• Michael C. Barnes & Stacey L. Worthy, Evaluating Motives: Two Simple Tests to Identify and Avoid Entanglement in Legally Dubious Urine Drug Testing Schemes, 11 J. Opioid Manag. 89 (2015).

• Michael C. Barnes, et al., Abuse-Deterrent Formulations: Transitioning the Pharmaceutical Market to Improve Public Health and Safety, 6 Therapeutic Advances in Drug Safety 1 (2015).

• Michael C. Barnes & Stacey L. Worthy, Achieving Real Parity: Increasing Access to Treatment for Substance Use Disorders Under the Patient Protection and Affordable Care Act and the Mental Health and Addiction Equity Act, 36 U Ark Little Rock L. Rev. 555 (2015).

• Michael C. Barnes & Stacey L. Sklaver, Applying Lessons from the Opioid Abuse Epidemic to Protect Consumers from Gray Market Biologics, 29 Notre Dame J.L. Ethics & Pub. Pol’y 375 (2015).

• Michael C. Barnes & Stacey L. Sklaver, Active Verification and Vigilance: A Method To Avoid Civil and Criminal Liability When Prescribing Controlled Substances, 15 DePaul J. Health Care L. 93 (2013).

• Michael C. Barnes & Gretchen Arndt, The Best of Both Worlds: Applying Federal Commerce and State Police Powers To Reduce Prescription Drug Abuse. 16 J. Health Care L. & Pol’y 271 (2013).

• Michael C. Barnes, et al., A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 1 & Part 2, J. Global Drug Pol’y & Prac.Vol. 3, Issue 4 (2009).

Speaking Engagements